US healthcare officials are working tirelessly to deliver coronavirus test results in a timely manner, but the process includes getting tested, having the sample processed and then delivering the results.
Now, a scientist has developed new technology that can produce a diagnosis in just a matter of seconds and with 98 percent accuracy.
Barath Narayanan, a scientist at the University of Dayton Research Institute, has designed a specific software code that can detect the disease just by scanning chest X-rays.
The process uses a deep learning algorithm that was trained using scans of those with and without the disease in order to search searches for markings associated with coronavirus.
Scroll down for video
A scientist has developed new technology that can produce a diagnosis in just a matter of seconds and with 98 percent accuracy. Left is a standard chest X-ray from a patient with COVID-19 (black and white image). The images were evaluated with the software and the red area is ‘region of interest’
Narayanan told DailyMail.com in an email: ‘What that means is that the software the software has decided something is there, in that particular region, and that particular something meets its criteria for classifying the image as having COVID markings (as opposed to not having COVID, or as opposed to having another lung disease).’
‘Using deep learning, a branch of artificial intelligence, the algorithm taught itself to identify these markings. As it has continued to train itself with additional X-rays in my ongoing research, it’s accuracy rate has gone from 98 percent to in excess of 99 percent.’
The system was adapted from existing medical diagnostic software in just a few hours and then licensed in less than three days.
Narayanan, who received his master’s and doctoral degrees in electrical engineering from the University of Dayton Research Institute (UD) said: ‘I wanted to do something for the common good, and medical imaging seemed a good way to do that.’
The process uses a deep learning algorithm that was trained using scans of those with and without the disease in order to search searches for markings associated with coronavirus
‘Software-based diagnostic tools can serve as a valuable, virtual second opinion for medical professionals, especially in parts of the world where medical teams are short-staffed.’
‘With additional research, these technologies can be fine-tuned to detect even the slightest anomalies on images—those that are difficult to see with the human eye—helping doctors diagnose and treat patients more quickly.’
Narayanan has been working with artificial intelligence for years with the hopes of developing technology that helps healthcare professionals diagnose and treat patients at a faster rate.
He has successfully developed software codes that detect lung and breast cancers, malaria, brain tumors, tuberculosis, diabetic retinopathy and pneumonia- all with 92 to 99 percent accuracy.
Once chest X-rays of a patient with and without coronavirus became available, Narayanan quickly got to work in designing a code that could detect the virus in scans.
Blue Eye Soft owner Srikanth Kodeboyina — an alumnus of UD — and his team further developed the technology, and he plans to submit a full proposal to the FDA for approval within a matter of days.
The company has already filed a provisional patent on the software.
Barath Narayanan, a scientist at the University of Dayton Research Institute, has designed a specific software code that can detect the disease in chest X-rays
‘We hope to be able to bring this new tool to market very quickly,’ Kodeboyina said noting that professionals around the world are lending their expertise to expedite the development of the product.
The coronavirus is currently ramping up in the US, but testing has increased since it made landfall – the country is testing more people a day than another other nation in the world.
But it’s been a slow ramp-up, and frustration still abounds over the length of time it takes to get tested, have the sample processed and get results back.
And testing capacity still remains uneven across the US and even on an individual basis.
Many celebrities, politicians and high-profile Americans have tested positive, even while reports emerge of people dying in US hospitals while awaiting results.
People have reported waiting six days before getting their test results and some have even died from the virus before they were delivered.
The ‘gold standard’ of testing for viral infections is still a diagnostic method called real-time RT-polymerase chain reaction (rRT-PCR) detection.
Such tests amplify the genetic material that defines a particular virus – In this case, SARS-CoV-2, which causes coronavirus – to make it detectable.
Coronavirus testing is now more widespread and faster tests are now FDA-approved – but some Americans still wait up to a week for their results
The Centers for Disease Control and Prevention’s (CDC) test works this way. Officials from the agency, the Food and Drug Administration (FDA) and the White House have said that millions of these tests have been shipped to labs across the US.
So far, Abbott’s five-minute test is the only approved COVID-19 diagnostic that uses a somewhat different technology.
Although Abbott’s test promises results in five minutes, and Cepheid’s promises them in 45, these timelines can be a bit misleading.
They refer to the amount of time it takes to run the tests within the confines of lab approved to analyze them.
That doesn’t include the time it takes to collect and transport the samples which, in most cases remains the same, no matter how long it takes the machine itself to process the sample.
A lot of people think, ‘oh, I’m going to go to my doctor’s office and they’re going to test me for COVI right there,” Dr Susan Whittier, a microbiologist who runs these very tests at New York Presbyterian Hospital, told DailyMail.com.
‘No, it still has to go to a CLIA [certified] lab.’
Most tests work effectively the same way the CDC’s does (pictured), but flaws in the kits caused initial delays and fury across the US
She walked DailyMail.com through the hour-by-hour process of coronavirus testing.
‘A lot of people believe the clock starts ticking the second the sample is taken, but [a lot depends on] where it’s going, there’s not constant transport,’ she said.
‘Even if [workers are] physically hand-walking samples over to the lab, that catches up with delays.’
It can take longer if these samples have to be driven from a testing site, say, a drive-thru one – to a lab.
And then there’s the matter of how many samples the lab receives at once, and how that can bottle-neck the process of preparing them to be run by analysis machines.
‘If we get three huge buckets of 60 to 100 specimens, it’s going to take an hour to an hour-and-a-half to unpack them, and they might be double- or triple-packed – every step of that process adds on to the turnaround,’ Dr Whittier explains.
The coronavirus is currently ramping up in the US, but testing has increased since it made landfall – the country is testing more people a day than another other nation in the world. However, more than 12, 000 people have died from the virus
Another 80 to 90 minutes might be tacked on to prepare and bleach the sample collection tubes, and then they’re taken to the biosafety cabinet – the sealed chambers where testing is done to limit exposure and contamination – where they might wait for 45 minutes to an hour before being put on the analysis machine.
‘Already, it’s been three to four hours since collection, and that’s before it even gets on the machine,’ says Dr Whittier.
‘But once it’s on the machine you can get results in maybe three hours.’
WHAT YOU NEED TO KNOW ABOUT BEING TESTED FOR CORONAVIRUS
On Tuesday, Vice President Mike Pence announced that any American can be tested for coronavirus as long as a doctor approves it.
The move appears to expand upon previous criteria needed for testing by the Centers for Disease Control and Prevention (CDC).
But how do you determine if you have symptoms of COVID-19 and when you should see a doctor?
We break down everything you need to know about being tested for the virus that has infected more than 120 Americans and killed at least nine.
WHAT ARE THE LATEST GUIDELINES FOR BEING TESTED?
There are three groups of people that the CDC recommends get tested.
1. People with symptoms such as fever, cough or shortness of breath who have been in ‘close contact’ with someone confirmed to have coronavirus
2. Patients with symptoms who have traveled to areas affected by the virus within the last 14 days
3. Those with symptoms who need to be hospitalized and no other cause for their illness is found. They don’t need to have a travel history or exposure to another patient
HOW DOES THIS DIFFER FROM THE PREVIOUS CRITERIA?
When the CDC first began testing, only those with a travel history to China – where the outbreak emerged – or those who had been exposed to a confirmed coronavirus patient were tested.
However, the agency says its criteria for testing is always ‘subject to change as additional information becomes available.’
WHAT TO DO IF YOU NEED A TEST?
Health officials strongly advise that anyone who believes they may be infected not show up unannounced at their doctor’s office in case they expose others to the highly-contagious disease.
Instead, the CDC suggests immediately calling your physician or healthcare provider.
‘Your healthcare professional will work with your state’s public health department and CDC to determine if you need to be tested for COVID-19,’ the CDC’s website states.
If you are suspected of having the virus, you will most likely get tested at a hospital.
The test involves getting a swab of the patient’s nostril and throat. If the patient has a wet cough, a sample of sputum (a mixture of saliva and mucus) will also be collected.
WHY HAS IT BEEN DIFFICULT FOR PEOPLE TO GET TESTED?
There have been multiple reports of people not having accessing to get tested.
The first batch of test kits that the CDC sent to state and local health departments were faulty, which led to a delay.
Secondly, the CDC had strict criteria for testing, which led to missed diagnoses of people who caught the virus from so-called ‘community spread,’ meaning it’s unknown how they were infected.
A third reason is that some health departments did not leave the decision to test up to doctors as the CDC suggested.
For instance, the Massachusetts Department of Public Health initially required doctors to call a hotline to determine if their patients met CDC criteria for testing.
Then, before the test could be administered, it had to be authorized at the State Public Health Lab.
WILL IT BE EASIER TO GET TESTED NOW?
Since the CDC’s testing fiasco, several health departments have either received new kits from the federal agency or made their own.
Additionally, the US Food and Drug Administration expanded its Emergency Use Authorization (EUA) policy so allow more labs can apply for approval to test for the virus.
The CDC that 75,000 test kits are currently available and more are being manufactured.
FDA Commissioner Dr Stephen Han told reporters on Monday that close to one million people would be tested by the end of the week.
But figures from the Association of Public Health Laboratories show that likely no more than 100,000 people would be tested by week’s end.